
    
      Total Lymphoid Irradiation and Anti-Thymocyte Globulin as Conditioning for Non-Myeloablative
      Allogeneic Hematopoietic Cell Transplantation for the Treatment of Myelodysplastic Syndromes
      and Myeloproliferative Disorders (except CML). To evaluate the feasibility and safety of
      TLI/ATG conditioning for allogeneic HCT for elderly patients or those with co-morbid
      conditions that preclude myeloablative transplantation for advanced stage MDS and MPD.
    
  